These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31282864)

  • 41. Impaired action potential initiation in GABAergic interneurons causes hyperexcitable networks in an epileptic mouse model carrying a human Na(V)1.1 mutation.
    Hedrich UB; Liautard C; Kirschenbaum D; Pofahl M; Lavigne J; Liu Y; Theiss S; Slotta J; Escayg A; Dihné M; Beck H; Mantegazza M; Lerche H
    J Neurosci; 2014 Nov; 34(45):14874-89. PubMed ID: 25378155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adolescent behavioral abnormalities in a Scn1a
    Bahceci D; Anderson LL; Occelli Hanbury Brown CV; Zhou C; Arnold JC
    Epilepsy Behav; 2020 Feb; 103(Pt A):106842. PubMed ID: 31870807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epilepsy channelopathies go neddy: stabilizing NaV1.1 channels by neddylation.
    Cannon SC
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33855971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.
    Yu FH; Mantegazza M; Westenbroek RE; Robbins CA; Kalume F; Burton KA; Spain WJ; McKnight GS; Scheuer T; Catterall WA
    Nat Neurosci; 2006 Sep; 9(9):1142-9. PubMed ID: 16921370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nav1.2 is expressed in caudal ganglionic eminence-derived disinhibitory interneurons: Mutually exclusive distributions of Nav1.1 and Nav1.2.
    Yamagata T; Ogiwara I; Mazaki E; Yanagawa Y; Yamakawa K
    Biochem Biophys Res Commun; 2017 Sep; 491(4):1070-1076. PubMed ID: 28784306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice.
    Yamagata T; Raveau M; Kobayashi K; Miyamoto H; Tatsukawa T; Ogiwara I; Itohara S; Hensch TK; Yamakawa K
    Neurobiol Dis; 2020 Jul; 141():104954. PubMed ID: 32445790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disordered breathing in a mouse model of Dravet syndrome.
    Kuo FS; Cleary CM; LoTurco JJ; Chen X; Mulkey DK
    Elife; 2019 Apr; 8():. PubMed ID: 31025941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene expression profiling in a mouse model of Dravet syndrome.
    Hawkins NA; Calhoun JD; Huffman AM; Kearney JA
    Exp Neurol; 2019 Jan; 311():247-256. PubMed ID: 30347190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A more efficient conditional mouse model of Dravet syndrome: Implications for epigenetic selection and sex-dependent behaviors.
    Williams AD; Kalume F; Westenbroek RE; Catterall WA
    J Neurosci Methods; 2019 Sep; 325():108315. PubMed ID: 31265868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biophysical characterization and modelling of SCN1A gain-of-function predicts interneuron hyperexcitability and a predisposition to network instability through homeostatic plasticity.
    Berecki G; Bryson A; Polster T; Petrou S
    Neurobiol Dis; 2023 Apr; 179():106059. PubMed ID: 36868483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.
    Ricobaraza A; Bunuales M; Gonzalez-Aparicio M; Fadila S; Rubinstein M; Vides-Urrestarazu I; Banderas J; Sola-Sevilla N; Sanchez-Carpintero R; Lanciego JL; Roda E; Honrubia A; Arnaiz P; Hernandez-Alcoceba R
    J Mol Med (Berl); 2023 Dec; 101(12):1587-1601. PubMed ID: 37819378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disordered autonomic function during exposure to moderate heat or exercise in a mouse model of Dravet syndrome.
    Sahai N; Bard AM; Devinsky O; Kalume F
    Neurobiol Dis; 2021 Jan; 147():105154. PubMed ID: 33144172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome.
    Tiraboschi E; Martina S; van der Ent W; Grzyb K; Gawel K; Cordero-Maldonado ML; Poovathingal SK; Heintz S; Satheesh SV; Brattespe J; Xu J; Suster M; Skupin A; Esguerra CV
    Epilepsia; 2020 Mar; 61(3):549-560. PubMed ID: 32096222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Temporal manipulation of the Scn1a gene reveals its essential role in adult brain function.
    Di Berardino C; Mainardi M; Brusco S; Benvenuto E; Broccoli V; Colasante G
    Brain; 2024 Apr; 147(4):1216-1230. PubMed ID: 37812819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case studies in neuroscience: a novel amino acid duplication in the NH
    Angus M; Peters CH; Poburko D; Brimble E; Spelbrink EM; Ruben PC
    J Neurophysiol; 2019 Nov; 122(5):1975-1980. PubMed ID: 31533007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early developmental alterations of CA1 pyramidal cells in Dravet syndrome.
    Jones SP; O'Neill N; Carpenter JC; Muggeo S; Colasante G; Kullmann DM; Lignani G
    Neurobiol Dis; 2024 Oct; 201():106688. PubMed ID: 39368670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Somatostatin-expressing parafacial neurons are CO
    Cleary CM; Milla BM; Kuo FS; James S; Flynn WF; Robson P; Mulkey DK
    Elife; 2021 May; 10():. PubMed ID: 34013884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.
    Kim HW; Quan Z; Kim YB; Cheong E; Kim HD; Cho M; Jang J; Yoo YR; Lee JS; Kim JH; Kim YI; Kim DS; Kang HC
    Brain Dev; 2018 Apr; 40(4):287-298. PubMed ID: 29295803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viral vector-mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome.
    Fadila S; Beucher B; Dopeso-Reyes IG; Mavashov A; Brusel M; Anderson K; Ismeurt C; Goldberg EM; Ricobaraza A; Hernandez-Alcoceba R; Kremer EJ; Rubinstein M
    J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37192002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine.
    Lemaire L; Desroches M; Krupa M; Pizzamiglio L; Scalmani P; Mantegazza M
    PLoS Comput Biol; 2021 Jul; 17(7):e1009239. PubMed ID: 34314446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.